FDA Investigator Bryan A Galvez

Bryan A Galvez has conducted inspections on 78 sites in 6 countries as of 12 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
78
Last Inspection Date:
12 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Germany, Italy, Korea (Republic of), Switzerland, Taiwan
FDA Investigators that have inspected at least one site in common with Bryan A Galvez:
Aaron J Adler, Adam R Cooke, Alan L Truong, Alan P Kurtzberg, Alexandra B Pitkin, Alexandria L Capuano, Althea A Williams, Amalia C Himaya, Amanda L Fyles, Amir Alavi, Ana Djurdjevic, Anderson, Andrew K Haack, PhD, Andrew S Limson, Angela Shepas, Angele C Smith, Angelica G Aziz, Anita Narula, PhD, Anthony G Emerson, April P Shaw, Arie C Menachem, Arsen Karapetyan, Ashar P Parikh, Babajide Michael Osunsanmi, Bichsa T Tran, Binh T Nguyen, Brenda Chavez, Brian J Ryan, Brien C Fox, Burnsb, Bush, Calvin B Koerner, Carla J Lundi, Carrie A Hughes, Caryn M Everly, Caryn M Mcnab, Cassandra L Abellard, Cathleen A Carr Sharpe, Celena Ngo, Celeta S Coves, Charles L Larson, Charlotte P Chang, Chelsea N Sealey, Christopher D Washington, Christopher M Jenner, Christopher R Czajka, Ciara J Bajulai Austin, Claudia Mperez Kasmarski, Comyar Shoghi, Crystal Monroy, Daniel J Lahar, Daniel R Solis, Daniel W Cline, Darren S Brown, Darrin E Davis, David A Oluwo, David G Whitman, David Serrano, David Y Hernandez, Davinna Ligons, PhD, Davis, Deborah A Greco, Deborah W Hsu, Debra D Devlieger, Dejon N Harris, Desiree C Iya, Devaughn Edwards, Diane Cvan Leeuwen, Diane L Raccasi, Diane R Weidley, Doan T Nguyen, PharmD, Dogbeda F Mackenzie, Dr. Jun Liu, PhD, Durell L Giles, Dyana K Stone, Eileen A Liu, Elizabeth M Dahl, Eric Zhu, Evelyn Wong, Finn A Slizza, Frances Namuswe, PhD, Francisco, Freddy Ortiz Colon, Frederick L Fricke, Garciam, Gary C Pecic, Jr, Gavin T Cua, Gene D Arcy, Geoffrey M Leist, George J Flynn, Ginger M Sykes, Grace E Mcnally, Grace P Santos, Greg K Keshishyan, Gregory A Berg, Hanna L Potter, Heidy C Perales, Hung H Do, MS, Ian L Mcwilliams, Jacob W Reynolds, Jacqueline Mdiaz Albertini, James A Barreto, James P Stallings, James R Fleckenstein, James R Montero, Jamie L Dion, Jane S Wernberg, Janet D Blount, Jazmine M Welcher, Jeannie Pradyanata, Jeff M Uriarte, Jeffery A Johnson, Jeffrey P Raimondi, Jennifer Crumb, Jennifer M Gogley, Jessie E Morris, Jinnie Kokiatkulkij, Jocelyn E Massey, Jocelyn E Sparks, Joe X Phillips, Joel D Hustedt, Joey V Quitania, John A Daubenspeck, John A Gonzalez, John L Stevens, Jolanna A Norton, Jose Acruz Gonzalez, Joseph C Yen, Joseph X Phillips, Juan A Morales, Juanita Banuelos, Juanj N Wu, Judy C Nepsa, Julie A Rorberg, Julie A Stocklin, Ka L Wong, Karen L Bauer, Kari M Johansen, Karthikeyan Kanakarajan (NMI), Katherine E Jacobitz, Kathleen B Swat, Kathy Chiu, Kathy Kuo, Keith P Iams, Kelley, Kelvin Cheung, Kelvin X Sanders, Kenneth O Gee, PhD, Kevin Lee, Kevin N Tran, Kevin T Gerrity, Kham Phommachanh, Khoa Nathanv Tran, Kim Lthomas Cruse, Kimberley A Hoefen, Kimberly M Lichter, Kirtida Patel, Kristen Nickens, PhD, Lakecha N Lewis, Lanita F Kelley, Laurenee L Adeoshun, Leonard H Lavi, Lewis K Antwi, Lilly O Barton, Liming Zhang, Linda F Murphy, Linda Linh N Adams, Linda Thai, Lindsey Brown, PhD, Ling Yu L Liu, Lisa Shin, Louis B Cencetti, LT Richard A Lyght, Lucas B Leake, Luis A Dasta, Marc A Jackson, Jr, Marco S Esteves, Marcus F Yambot, Maria A Reed, Maria C Agpaoa, Maria C Fermin, Marie B Buen Bigornia, Marie Falcone, Marie T Falcone, Marijo B Kambere, PhD, Marion W Nadeau, Mariza M Jafary, Mark A Tucker, Mark C Saale, Mark E Chan, Matthew B Casale, Matthew J Gretkierewicz, Matthew J Johnson, Matthew R Dionne, Maurice M Sheehan, Michael A Charles, Michael D Garcia, Michael J Kuchta, Michael R Goga, Michael S Araneta, Michael S Call, Michael Shanks, MS, Michael T Cyrus, Miguel A Martinez Perez, Mihaly S Ligmond, Mindy M Chou, Minh D Phan, Mra M Barbosar, Nadeem I Chaudhry, Natalie J Ayoub, Naveen B Walker, Nayan J Patel, Neal L Adams, Nelly N Tran, Nianna C Burns, Nicholas L Hunt, Omotunde O Osunsanmi, Patricia P Wrona, Patrick C Klotzbuecher, Paul A Bonneau, Pearl C Ozuruigbo, Phal K Chhun, Phillip L Toy, Prabhu P Raju, Rabin N Ghoshal, Raymond T Oji, Raymond W Brullo, Richard A Abate, Richard C Chiang, Richard W Tubb, Richmond K Yip, Ricki A Chase, Robert C Coleman, Robert C Hoover, Robert T Lorenz, Rumany C Penn, PharmD, Saied A Asbagh, Saleem A Akhtar, Samantha E Rafferty, Samina S Khan, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Sara Jdent Acosta, Sarah A Hassas, Satheesh Thomas, Sean P Desbrow, Selene T Torres, Shannon B Ruelle, Shaquenta Y Perkins, Sherrie M La, Siobhan A Gallagher, Siobhan G Taylor, Sonya L Karsik, RAC, Sparky L Bartee, Stephanie A Slater, MS, Stephen D Eich, Steven C Madzo, Steven E Porter, Jr, Sudipan Karmakar, Sumit Sen, Sundy V Sedwick, Susan K Bain, Susan M Jackson, Taichun Qin, PhD, Tamala P Magee, Tamara L Ely, Tammy Vasquez Hancock, Tanya E Malais, Tara L Stockton, Tawny L Colling, Teresa I Navas, Teresa T Cain, Terrance L Thomas, Terri L Dodds, Thao T Kwan, Thao X Tran, Theressa B Smith, Thomas J Arista, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Timothy T Kapsala, Tracey T Duong, Trudy R Papson, Truong Xuan Nguyen (Andy), Trushani T Desai, Tuan A Nguyen, Tuan D Tran, Uttaniti Limchumroon (Tom), Vashti E Bocker, Vickie L Anderson, Vioela J Caze, Virgilio F Pacio, CSO, Walden H Lee, Wayne W Grundstrom, Wenzheng Wendy Zhang, William J Leonard, Yasamin Ameri, Yi Lin, Yi Wang, PhD, Youkeun Kim, Yumi J Hiramine, Yun Wu, PhD, Yvette E Guillermo, Yvette Mlacour Davis, Yvins Dezan, Yvonne T Lacour, Zachary A Bogorad, Zachary L Miller

Bryan A Galvez's Documents

Publish Date Document Type Title
December, 2019 FDA 483 Response United Exchange Corp. - Form 483R, 2019-12-20
April, 2019 FDA 483 Global Vitality Inc. - Form 483, 2019-04-24
December, 2019 FDA 483 United Exchange Corp. - Form 483, 2019-12-04
January, 2023 FDA 483 Tanvex BioPharma USA, Inc - Form 483, 2023-01-24
November, 2018 FDA 483 Kadesh International - Form 483, 2018-11-07
September, 2021 FDA 483 PYRAMID Laboratories, Inc. - Form 483, 2021-09-29
December, 2019 FDA 483 United Exchange Corp. - Form 483, 2019-12-19
June, 2021 FDA 483 J.M. Huber Micropowders, Inc. - Form 483, 2021-06-25
September, 2022 FDA 483 Defender SD Manufacturing LLC - Form 483, 2022-09-22
March, 2021 FDA 483 ADAMSON ANALYTICAL LABORATORIES INC - Form 483, 2021-03-23
July, 2018 FDA 483 Finemost Corporation - Form 483, 2018-07-26
May, 2021 FDA 483 Response Alliance Medical Products, Inc. (dba Siegfried Irvine) - Form 483R, 2021-06-11
September, 2021 FDA 483 Response PYRAMID Laboratories, Inc. - Form 483R, 2021-09-29
November, 2018 FDA 483 Fill it Pack It Inc - Form 483, 2018-11-05
September, 2018 FDA 483 MedisourceRx - Form 483, 2018-09-27
July, 2022 FDA 483 Kolmar Korea Co., Ltd - Form 483, 2022-07-07
August, 2021 FDA 483 Response Teva Parenteral Medicines, Inc. - Form 483R, 2021-09-13
March, 2018 FDA 483 NuCare Pharmaceuticals,Inc. - Form 483, 2018-03-21
September, 2021 EIR PYRAMID Laboratories, Inc. - EIR, 2021-09-29
March, 2019 FDA 483 McGuff Pharmaceuticals, Inc. - Form 483, 2019-03-26
November, 2022 FDA 483 NOVARTIS FARMA SPA - Form 483, 2022-11-11
August, 2021 FDA 483 Teva Parenteral Medicines, Inc. - Form 483, 2021-08-20
November, 2018 FDA 483 We Pack It All, LLC - Form 483, 2018-11-01
August, 2018 FDA 483 Health Plus Inc. - Form 483, 2018-08-16
June, 2019 FDA 483 Bachem Americas, Inc. - Form 483, 2019-06-12
May, 2021 FDA 483 Alliance Medical Products, Inc. (dba Siegfried Irvine) - Form 483, 2021-05-21
December, 2021 FDA 483 Clinical Formula LLC - Form 483, 2021-12-03
December, 2018 FDA 483 Panrosa Enterprises, Inc. - Form 483, 2018-12-18
July, 2022 FDA 483 PL COSMETIC - Form 483, 2022-07-01
December, 2017 FDA 483 Response bB BIOCHEM LABORATORIES INC. - Form 483R, 2018-01-09
October, 2019 FDA 483 Auro Pharmacies, Inc DBA Central Drugs - Form 483, 2019-10-18
June, 2019 FDA 483 Response Bachem Americas, Inc. - Form 483R, 2019-07-03
March, 2021 FDA 483 Response ADAMSON ANALYTICAL LABORATORIES INC - Form 483R, 2021-04-12
September, 2019 FDA 483 Pacifica Pharmacy - Form 483, 2019-09-09
August, 2023 FDA 483 TEH SENG PHARMACEUTICAL MFG. CO., LTD. 3RD PLANT - Form 483, 2023-08-04
July, 2019 FDA 483 DENTAL-Kosmetik GmbH & Co. KG - Form 483, 2019-07-19
March, 2019 FDA 483 Response McGuff Pharmaceuticals, Inc. - Form 483R, 2019-04-16
October, 2020 EIR DDL Inc. - EIR, 2020-10-01
August, 2022 FDA 483 Auro Pharmacies, Inc. - Form 483, 2022-08-12
September, 2023 FDA 483 Clinical Resolution Laboratory, Inc. - Form 483, 2023-09-29
June, 2023 FDA 483 Nelson Laboratories, LLC - Form 483, 2023-06-02
June, 2019 EIR Bachem Americas, Inc. - EIR, 2019-06-12
April, 2018 EIR Proficient Rx LP - EIR, 2018-04-05
December, 2017 FDA 483 bB BIOCHEM LABORATORIES INC. - Form 483, 2017-12-18
May, 2021 EIR Alliance Medical Products, Inc. (dba Siegfried Irvine) - EIR, 2021-05-21
July, 2019 FDA 483 Ivers-Lee SA - Form 483, 2019-07-05
October, 2017 FDA 483 Nexgen Pharma, Inc. - Form 483, 2017-10-20
August, 2016 FDA 483 Response RF Surgical System Inc Technical Center - Form 483R, 2016-09-12
February, 2024 FDA 483 Bioduro LLC - Form 483, 2024-02-23
April, 2023 FDA 483 Eyenovia, Inc. - Form 483, 2023-04-05
May, 2018 FDA 483 Clinical Resolution Laboratory, Inc. - Form 483, 2018-05-15
January, 2019 FDA 483 ALS Group USA, Corp. - Form 483, 2019-01-25
August, 2016 FDA 483 RF Surgical System Inc Technical Center - Form 483, 2016-08-18

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more